PRESS RELEASE published on 01/13/2025 at 18:00, 1 year 6 months ago Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie Atlas Special Opportunities, LLC convertit 4 obligations convertibles en Oxurion pour une augmentation de capital de 100 000 EUR, soutenant le développement de médicaments pour préserver la vision des personnes âgées Obligations Convertibles Augmentation De Capital Atlas Special Opportunities Médicaments Innovants Oxurion
BRIEF published on 01/06/2025 at 18:05, 1 year 7 months ago Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Transparency Biopharmaceutical Shareholding Atlas Special Opportunities Oxurion
BRIEF published on 01/06/2025 at 18:05, 1 year 7 months ago Oxurion reçoit une notification de transparence de la part d'Atlas Special Opportunities LLC Actionnariat Transparence Biopharmaceutique Oxurion Opportunités Spéciales Atlas
PRESS RELEASE published on 01/06/2025 at 18:00, 1 year 7 months ago Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Oxurion NV received a transparency notification from Atlas Special Opportunities, LLC revealing a stake above 15% threshold due to purchase of voting securities Transparency Notification Biopharmaceutical Atlas Special Opportunities Ophthalmic Therapies Oxurion NV
PRESS RELEASE published on 01/06/2025 at 18:00, 1 year 7 months ago Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities LLC Oxurion NV receives transparency notification from Atlas Special Opportunities LLC regarding ownership of 624,817 shares, exceeding the 15% threshold Transparency Notification Share Ownership Atlas Special Opportunities LLC Oxurion NV Ophthalmological Therapies
BRIEF published on 01/03/2025 at 18:05, 1 year 7 months ago Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Shares Transparency Biopharmaceutical Atlas Special Opportunities Oxurion
BRIEF published on 01/03/2025 at 18:05, 1 year 7 months ago Oxurion reçoit une notification de transparence de la part d'Atlas Special Opportunities LLC Actions Transparence Biopharmaceutique Oxurion Opportunités Spéciales Atlas
PRESS RELEASE published on 01/03/2025 at 18:00, 1 year 7 months ago Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Oxurion NV received a transparency notification under Belgian Transparency legislation from Atlas Special Opportunities, LLC, regarding the sale of voting securities Transparency Notification Atlas Special Opportunities LLC Oxurion NV Belgian Legislation Retinal Disease Therapy
PRESS RELEASE published on 01/03/2025 at 18:00, 1 year 7 months ago Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities LLC Oxurion NV announces receipt of transparency notification regarding shareholding. Bio-pharmaceutical company developing ophthalmological therapies. Refer to website for more details Transparency Notification Shareholding Belgium Oxurion NV Ophthalmological Therapies
BRIEF published on 12/31/2024 at 18:05, 1 year 7 months ago Oxurion reporte une transaction stratégique en raison de discussions en cours Report Transaction Stratégique Oxurion Discussions Financières Louvain
Published on 08/07/2026 at 23:15, 10 hours 11 minutes ago Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 10 hours 26 minutes ago Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/07/2026 at 22:30, 10 hours 56 minutes ago UraniumX Deploys $3.8 Million to Athabasca Basin Exploration
Published on 08/07/2026 at 22:15, 11 hours 11 minutes ago Noram Lithium Engages 1353656 BC Ltd. for Marketing and Management Consulting Services
Published on 08/07/2026 at 23:21, 10 hours 5 minutes ago EQS-Adhoc: Northern Data Group reports Q2 2026 including the adverse fair value movement on contingent consideration
Published on 08/07/2026 at 19:30, 13 hours 56 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/07/2026 at 19:15, 14 hours 11 minutes ago ABO Energy Agrees Sale of Its Polish and Hungarian Subsidiaries
Published on 08/07/2026 at 18:10, 15 hours 16 minutes ago Stabilus SE: Andreas Jaeger steps down as Chief Financial Officer at his own request
Published on 08/07/2026 at 18:00, 15 hours 26 minutes ago E-PANGO: Composition du capital au 31 juillet 2026
Published on 08/07/2026 at 18:54, 14 hours 32 minutes ago Covivio - Déclaration des transactions sur actions propres réalisées du 03 août 2026 au 07 août 2026
Published on 08/07/2026 at 18:54, 14 hours 32 minutes ago Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
Published on 08/07/2026 at 18:40, 14 hours 45 minutes ago Disclosure of transactions in own shares from August 3 to August 7, 2026
Published on 08/07/2026 at 18:40, 14 hours 45 minutes ago Déclaration hebdomadaire d'opérations effectuées du 3 au 7 août 2026
Published on 08/07/2026 at 18:00, 15 hours 26 minutes ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 juillet 2026
